Topix has acquired ClarityRx, a skincare company that specialises in spa-dispensed products.

Backed by private-equity firm New Mountain Capital, Topix is a skincare products manufacturer offering a portfolio of brands sold across the medical and natural channels.

Upon completion of the transaction, ClarityRx is expected to benefit from Topix’s scale and experience in the US market.

The transaction will also enable ClarityRx to speed up its investment in new product development, focusing on beautician training and partnership.

ClarityRx will continue to operate from Newbury Park, California, and will be headed by co-founders Karla Keene and Darcie Crandall.

“We look forward to achieving new heights for ClarityRx in partnership with Topix and continuing to deliver world-class products and services for our customers.”

Keene and Crandall said: “Topix’s commitment to furthering the ClarityRx philosophy and mission, while providing us with the resources to enhance our product offering is the exact partnership that we had envisioned for ClarityRx’s next phase of growth.

“We look forward to achieving new heights for ClarityRx in partnership with Topix and continuing to deliver world-class products and services for our customers.”

Topix CEO Brenda Wu said: “ClarityRx is a highly differentiated, modern brand that delivers what today’s discerning consumers are seeking, the best of science and nature.

“We see tremendous potential in ClarityRx and are eager to further support the brand and their customers, including the over four hundred Hand & Stone franchises.”

California-based law firm Stubbs Alderton & Markiles acted as legal advisor to ClarityRx whereas Lowenstein Sandler offered legal counsel to Topix and New Mountain Capital.